-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
HCW Biologics Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2021 to Q2 2025.
- HCW Biologics Inc. Cost of Revenue for the quarter ending June 30, 2025 was $5.24K, a 98.8% decline year-over-year.
- HCW Biologics Inc. Cost of Revenue for the twelve months ending June 30, 2025 was $666K, a 75.3% decline year-over-year.
- HCW Biologics Inc. annual Cost of Revenue for 2024 was $1.61M, a 29.5% decline from 2023.
- HCW Biologics Inc. annual Cost of Revenue for 2023 was $2.28M, a 44.8% decline from 2022.
- HCW Biologics Inc. annual Cost of Revenue for 2022 was $4.14M.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)